Tafenoquine Redux: 60 Degrees Pharma’s Malaria Drug Gets Its Turn At US FDA Panel

Extended dosing required for prophylactic indication could raise more advisory committee concerns about safety than the one-time dose of GlaxoSmithKline’s formulation, which was recently approved for prevention of relapse.

Malaria - Handwritten Diagnosis in the Disease Extract. Medicine Concept with Heap of Pills, Close View, Selective Focus. Malaria Inscription in Medical History. Close View of Medicine Concept. 3D.

Six days after the US FDA approved GlaxoSmithKline PLC’s Krintafel (tafenoquine) for prevention of malaria relapse, an advisory committee will consider [60 Degrees Pharmaceuticals LLC]’s application for the same compound for malaria prophylaxis.

However, the prophylactic indication and extended dosing regimen with 60 Degrees’ tafenoquine (TQ) formulation could raise more safety concerns for...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA Performance Tracker

More from Regulatory Trackers